We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LUN:TSXLundin Mining Corporation Analysis

Data as of 2026-05-13 - not real-time

CA$40.65

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Lundin Mining is trading at CAD 40.65, well below its DCF fair value of CAD 75.53, indicating a sizable margin of safety. The stock sits above its 20‑day (37.15) and 50‑day (35.88) SMAs and comfortably over the 200‑day SMA (27.70), while the RSI at 64.7 shows momentum without being overbought. A bullish MACD histogram (+0.36) and increasing volume reinforce the short‑term upside potential. Recent Q1 2026 results beat expectations, with revenue up 26% YoY to US$1.16 bn and profit margin expanding to 33.5%, supporting the buy consensus from 24 analysts.
Fundamentally, Lundin delivers strong cash generation (free cash flow ≈ CAD 1.77 bn) and a robust ROE of 22.2% on a modest dividend yield of 0.27% with a very low payout ratio (5.7%), suggesting dividend sustainability. The company’s high beta (~1.6) and 30‑day volatility (≈ 58%) reflect the inherent commodity and geopolitical risks of its Chilean, Brazilian and Argentine operations, but the balance sheet remains healthy with cash exceeding debt. Overall, the blend of undervaluation, solid earnings growth, and resilient cash flow makes the stock attractive for investors with a medium‑to‑long horizon.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (price above SMAs, MACD bullish)
  • Earnings beat and strong revenue growth
  • Significant valuation gap to DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained cash flow and low dividend payout ratio
  • Exposure to copper price cycles
  • Moderate valuation relative to peers

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term copper demand fundamentals
  • Undervalued DCF estimate offering upside
  • Strong balance sheet with cash exceeding debt

Key Metrics & Analysis

Financial Health

Revenue Growth26.00%
Profit Margin33.55%
P/E Ratio21.4
ROE22.18%
ROA8.42%
Debt/Equity6.22
P/B Ratio3.8
Op. Cash FlowCA$1.7B
Free Cash FlowCA$1.8B

Technical Analysis

TrendBullish
RSI64.7
SupportCA$33.25
ResistanceCA$42.58
MA 20CA$37.15
MA 50CA$35.88
MA 200CA$27.70
MACDBullish
VolumeIncreasing
Fear & Greed Index89.55

Valuation

Fair ValueCA$75.53
Target PriceCA$39.22
Upside/Downside-3.51%
GradeUndervalued
TypeBlend
Dividend Yield0.27%

Risk Assessment

Beta1.64
Volatility58.66%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.